ReP USP - Resultado da busca

Artigo de periodico
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma (2021)
Tesileanu, C. Mircea S.; Van den Bent, Martin; Sanson, Marc; Wick, Wolfgang; Brandes, Alba; Clement, Paul M.; Erridge, Sara C.; Vogelbaum, Michael A.; Nowak, Anna; Baurain, Jean; Mason, Warren P.; Wheeler, Helen; Chinot, Olivier L.; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Taal, Walter; Rudà, Roberta; Weller, Michael; McBain, Catherine; Linde, Myra E. van; Sabedot, Thais S.; Hoogstrate, Youri; Deimling, Andreas von; Heer, Iris de; IJcken, Wilfred F. J. van; Brouwer, Rutger W. W.; Aldape, Kenneth; Jenkins, Robert B.; Dubbink, Hendrikus; Kros, Johan M.; Wesseling, Pieter; Cheung, Kin Jip; Golfinopoulos, Vassilis; Baumert, Brigitta; Gorlia, Thierry; Noushmehr, Houtan; French, Pim
Source: Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, GLIOMA, MUTAÇÃO, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, v. 23, n. 9, p. 1547-1559, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab088. Acesso em: 19 nov. 2024.
APA
Tesileanu, C. M. S., Van den Bent, M., Sanson, M., Wick, W., Brandes, A., Clement, P. M., et al. (2021). Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, 23( 9), 1547-1559. doi:10.1093/neuonc/noab088
NLM
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/neuonc/noab088
Vancouver
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/neuonc/noab088
Artigo de periodico
A serum-based DNA methylation assay provides accurate detection of glioma (2021)
Sabedot, Thais S; Malta, Tathiane M; Snyder, James; Nelson, Kevin; Wells, Michael; Carvalho, Ana C. de; Mukherjee, Abir; Chitale, Dhananjay A; Mosella, Maritza S; Sokolov, Artem; Asmaro, Karam P; Robin, Adam; Rosenblum, Mark L; Mikkelsen, Tom; Rock, Jack; Poisson, Laila M; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Iavarone, Antonio; Castro, Ana Valeria; Noushmehr, Houtan
Source: Neuro-Oncology. Unidade: FMRP
Subjects: BIOMARCADORES, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, BIÓPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais S et al. A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, v. 23, n. 9, p. 1494-1508, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab023. Acesso em: 19 nov. 2024.
APA
Sabedot, T. S., Malta, T. M., Snyder, J., Nelson, K., Wells, M., Carvalho, A. C. de, et al. (2021). A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, 23( 9), 1494-1508. doi:10.1093/neuonc/noab023
NLM
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/neuonc/noab023
Vancouver
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/neuonc/noab023
Trabalho de evento-resumo periodico
Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification (2019)
Ng, Hon Keung; Li, Kay Ka-Wai; Malta, Tathiane M.; Shi, Zhi-feng; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Conference British Neuro-Oncology Society - BNOS. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, NEOPLASIAS CEREBRAIS, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NG, Hon Keung et al. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz167.006. Acesso em: 19 nov. 2024. , 2019
APA
Ng, H. K., Li, K. K. -W., Malta, T. M., Shi, Z. -feng, & Noushmehr, H. (2019). Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz167.006
NLM
Ng HK, Li KK-W, Malta TM, Shi Z-feng, Noushmehr H. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification [Internet]. Neuro-Oncology. 2019 ; 21 iv2.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/neuonc/noz167.006
Vancouver
Ng HK, Li KK-W, Malta TM, Shi Z-feng, Noushmehr H. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification [Internet]. Neuro-Oncology. 2019 ; 21 iv2.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/neuonc/noz167.006

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration